Breaking News

CordenPharma Expands CDMO Capabilities

Completes acquisition of 3 GMP manufacturing facilities from Vifor Pharma for non-sterile drug products.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CordenPharma, a full-service contract development and manufacturing organization (CDMO) supplying APIs, excipients, drug products, and associated packaging services, has completed the acquisition of three manufacturing facilities from Vifor Pharma, to be ultimately renamed Corden Pharma Fribourg S.A. (including its Ettingen branch) in Switzerland, and Corden Pharma Lisbon S.A. in Portugal. “We welcome the three sites and their employees as new members to the CordenPharma Group and look ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters